Cefepime
Kathryn Dzintars, Pharm.D., BCPS
,
Paul A. Pham, Pharm.D.
Pediatric Dosing Author:
Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Pneumonia
caused by
S. pneumoniae
Including cases associated with concurrent bacteremia,
P. aeruginosa
,
K. pneumoniae
or
Enterobacter
species
.
Febrile neutropenia (empiric therapy)
Uncomplicated
and
complicated
urinary tract infections including pyelonephritis (+/- bacteremia) caused by
E. coli
,
K. pneumoniae
,
or
P. mirabilis
Uncomplicated skin and skin-structure infections caused by MSSA or
S. pyogenes
.
Complicated
intra-abdominal infections
(in combination with
metronidazole
) caused by
E. coli
, viridans group streptococci,
P. aeruginosa
,
K. pneumoniae
,
Enterobacter
species
, or
B. fragilis
.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Shunt infections
, CNS
Appendicitis
(with
metronidazole
)
Diverticulitis
(with
metronidazole
)
Intra-abdominal abscess
(with
metronidazole
)
Osteomyelitis, acute
Osteomyelitis, chronic
Diabetic foot infection
(with
metronidazole
or
clindamycin
)
Hardware associated septic arthritis
Acute exacerbations of chronic bronchitis
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved